dc.contributor.author | Conseil exécutif, 120 | |
dc.coverage.spatial | Genève | en |
dc.date.accessioned | 2012-03-14T06:39:59Z | |
dc.date.available | 2012-03-14T06:39:59Z | |
dc.date.issued | 2007 | |
dc.identifier.govdoc | EB120/33 | |
dc.identifier.uri | http://www.who.int/iris/handle/10665/22068 | |
dc.description | Conseil exécutif Cent vingtième session, Point 9.1 de l’ordre du jour provisoire, 6 p. | en |
dc.language.iso | fr | en |
dc.publisher | Organisation mondiale de la Santé | en |
dc.subject | Pharmaceutical products | en |
dc.subject | Vaccines | en |
dc.subject | Food safety | en |
dc.subject.mesh | Biological Products | en |
dc.subject.mesh | Vaccines | en |
dc.subject.mesh | Drug Residues | en |
dc.subject.mesh | Food Contamination | en |
dc.subject.mesh | Veterinary Drugs | en |
dc.subject.mesh | Psychotropic Drugs | en |
dc.title | Comités d’experts et groupes d’étude : rapport du Secrétariat | en |
dc.type | Governing body documents | en |
dc.subject.meshqualifier | standards | en |
dc.subject.meshqualifier | toxicity | en |
dc.subject.meshqualifier | adverse effects | en |
who.relation.languageVersion | 10665/21971 | en |
who.relation.languageVersion | 10665/25548 | en |
who.relation.languageVersion | 10665/24793 | en |
who.relation.languageVersion | 10665/24201 | en |
who.relation.languageVersion | 10665/23372 | en |
who.relation.languageVersion | 10665/69562 | en |